Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone

Serum antimüllerian hormone is not predictive of oocyte quality in vitro fertilization

(2009) F. Guerif et al.   ANNALES D ENDOCRINOLOGIE

Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception

(2009) S. M. Nelson et al.   HUMAN REPRODUCTION

Anti-Mullerian hormone (AMH): what do we still need to know?

(2009) A. La Marca et al.   HUMAN REPRODUCTION

Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)

(2009) A. La Marca et al.   HUMAN REPRODUCTION UPDATE

Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks

(2009) Kutluk Oktay et al.   JOURNAL OF CLINICAL ONCOLOGY

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count

(2008) Simone L. Broer et al.   FERTILITY AND STERILITY

A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation

(2008) Kannamannadiar Jayaprakasan et al.   FERTILITY AND STERILITY

Implementing a Survivorship Care Plan for Patients With Breast Cancer

(2008) Patricia A. Ganz et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety of Fertility Preservation by Ovarian Stimulation With Letrozole and Gonadotropins in Patients With Breast Cancer: A Prospective Controlled Study

(2008) Amr A. Azim et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve

(2007) J KWEE et al.   FERTILITY AND STERILITY